Skin Cancer Merkel Cell Carcinoma (Stage I–IV)
Reviewed by Oncology Team, HealOnco | Last updated: 2026-04
What Merkel Cell Carcinoma (Stage I–IV) Means
Rare neuroendocrine tumor. Localized disease (stage I–II): lesion ≤2 cm without or with regional nodes. Stage III: any size with nodal involvement. Stage IV: distant metastases. SLNB mandatory for staging.
Treatment Approach for Merkel Cell Carcinoma (Stage I–IV)
Stage I–II: wide local excision (1–2 cm margins) + SLNB + adjuvant radiation. Stage III–IV: systemic therapy, primarily checkpoint inhibitors (avelumab, pembrolizumab, nivolumab). Chemotherapy (combination carboplatin + etoposide) for MCPyV-negative or rapidly progressive disease. Palliative care for metastatic disease. Follow-up: imaging every 3 months; clinical exams monthly during treatment.
Survival Rates and Prognosis
The 5-year survival rate for skin cancer at Merkel Cell Carcinoma (Stage I–IV) is approximately 5-year survival: 70–80% (stage I); 50% (stage II–III); 25% (stage IV). Survival rates are statistical averages drawn from large patient populations and may not reflect your individual outcome. Factors that influence your specific prognosis include your age, overall health, tumour biology, and how well the cancer responds to treatment.
Important: These numbers are drawn from historical data. Newer treatments available today may improve outcomes beyond what published statistics show. Discuss your individual prognosis with your oncologist.
How Other Stages Compare
| Stage | 5-Year Survival | Treatment |
|---|---|---|
| Non-Melanoma: Low-Risk BCC/SCC | 5-year recurrence-free survival: >95% | Mohs micrographic surgery (preferred), wide local excision, curettage and… |
| Non-Melanoma: High-Risk BCC/SCC | 5-year recurrence-free survival: 50–80%; metastatic risk 5–20% for aggressive SCC variants | Mohs micrographic surgery or wide local excision with adequate margins (5–10… |
| Melanoma Stage I (T1–2, N0, M0) | 5-year survival: 85–95% (stage IA); 70–80% (stage IB) | Wide local excision (10–20 mm margins depending on thickness and anatomic… |
| Melanoma Stage II (T3–4, N0, M0) | 5-year survival: 60–75% (stage IIA–IIB); 50–60% (stage IIC) | Wide local excision (10–20 mm margins). SLNB strongly recommended. Adjuvant… |
| Melanoma Stage III (T1–4, N1–3, M0) | 5-year survival: 50–70% (stage IIIA); 40–50% (stage IIIB); 25–40% (stage IIIC) | Complete lymph node dissection (CLND) historically standard; trend toward… |
| Melanoma Stage IV (Any T, Any N, M1) | 5-year survival: 20–40% (with modern immunotherapy/targeted therapy); 5–15% (historical, pre-checkpoint inhibitor era) | Systemic therapy: (1) Checkpoint inhibitor monotherapy (pembrolizumab,… |
Skin Cancer Treatment in Top Cities
Diagnosed with Merkel Cell Carcinoma (Stage I–IV) Skin Cancer?
Our specialists can review your reports and create a personalised treatment plan.
Get a Free Consultation